Skip to content
Top Menu
June 17, 2025
  • About Us
  • Contact Details
  • Grievance
  • Privacy Policy
  • Terms Of Use
  • Facebook
  • Twitter
  • Instagram
  • Youtube
The Samikhsya

The Samikhsya

Odia
  • Home
  • Special
  • National
  • Business
  • Entertainment
  • Culture
  • International
  • Sports
  • Sc & Tech
  • Health
Main Menu

Tag: Covaxin

National / News Update

Covishield, Covaxin price cut to Rs 225 per dose for private hospitals

April 9, 2022 - by The Samikhsya

New Delhi: The prices of Serum Institute’s Covid vaccine COVISHIELD and Bharat Biotech’s COVAXIN have been slashed significantly. CEO of Serum Institute of India, SII Adar Poonawalla said in a …

Covishield, Covaxin price cut to Rs 225 per dose for private hospitals Read More
National / Special

Bharat Biotech gets nod to conduct phase-3, booster trial of intranasal vaccine

January 5, 2022 - by The Samikhsya

New Delhi: The subject expert committee (SEC) of Drugs controller General (India) has recommended that Hyderabad-based Bharat Biotech can conduct phase- three trials on its intranasal vaccine. The company had …

Bharat Biotech gets nod to conduct phase-3, booster trial of intranasal vaccine Read More
National / News Update

Covid Vaccination of children between 15 and 18 years begins from today

January 3, 2022 - by The Samikhsya

New Delhi: COVID-19 vaccination for children in the age group of 15 to 18 years has begun all over the country. The vaccine option for children is only Covaxin for …

Covid Vaccination of children between 15 and 18 years begins from today Read More
National / News Update

Bharat Biotech’s Covaxin gets nod for emergency use in children

December 26, 2021 - by The Samikhsya

New Delhi: Bharat Biotech’s COVID-19 vaccine ‘Covaxin’ has received approval for Emergency use in children between 12 to 18 years of age. In a statement, Bharat Biotech said, Covaxin is …

Bharat Biotech’s Covaxin gets nod for emergency use in children Read More
National / News Update

DCGI approves Phase 2,3 clinical trial of Covaxin in the age group of 2 to 18 Years

May 13, 2021 - by The Samikhsya

New Delhi, The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission …

DCGI approves Phase 2,3 clinical trial of Covaxin in the age group of 2 to 18 Years Read More
Health / National / News Update

IMS AND SUM Hospital prepared for lunch of COVID Vaccine on Saturday

January 15, 2021January 15, 2021 - by The Samikhsya

Bhubaneswar: Preparations for launching the much-awaited Covid-19 vaccine on Saturday have been completed at the Institute of Medical Sciences and SUM Hospital, faculty of medicine of Siksha ‘O’ Anusandhan (SOA). …

IMS AND SUM Hospital prepared for lunch of COVID Vaccine on Saturday Read More
Phase-3 trial of Covaxin begins at Odisha's SUM Hospital
Health / Special

Phase-3 trial of Covaxin begins at Odisha’s SUM Hospital

November 20, 2020 - by IANS

Bhubaneswar: The third phase human trial of Covid-19 vaccine candidate ‘Covaxin’ began at the Institute of Medical Sciences and SUM Hospital here, said an official on Friday. This is the only …

Phase-3 trial of Covaxin begins at Odisha’s SUM Hospital Read More
Haryana health minister Vij gets trial dose of Covid vaccine
National / News Update

Haryana health minister Vij gets trial dose of Covid vaccine

November 20, 2020 - by IANS

Chandigarh: Haryana Health Minister Anil Vij was administered a trial dose of India-made coronavirus vaccine Covaxin on Friday. He was among the first volunteers for the third phase trial of the …

Haryana health minister Vij gets trial dose of Covid vaccine Read More
Phase-3 trial of Covaxin begins at Odisha's SUM Hospital
Health / Special

Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech

November 16, 2020 - by IANS

Hyderabad: Even as India’s first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion …

Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech Read More
Health / National / News Update

Third phase human trial of Covaxin to commence at IMS and SUM Hospital soon

October 25, 2020 - by IANS

Bhubaneswar: The third phase of the human trial of COVAXIN, the much-awaited indigenous vaccine being developed against Covid-19, will commence at the Institute of Medical Sciences and SUM Hospital here …

Third phase human trial of Covaxin to commence at IMS and SUM Hospital soon Read More

Posts navigation

1 2 Next

Business News

  • Cyprus–India Relations: Joint Declaration Signed to Implement Comprehensive Partnership

    Cyprus–India Relations: Joint Declaration Signed to Implement Comprehensive Partnership

  • Paula’s Choice Skincare Makes Retail Debut in India Through Nykaa Partnership

    Paula’s Choice Skincare Makes Retail Debut in India Through Nykaa Partnership

  • PM Modi in Cyprus: Holds Business Meet with President Christodoulides

    PM Modi in Cyprus: Holds Business Meet with President Christodoulides

  • Ahmedabad Plane Tragedy: HDFC Life Simplifies Claim Submission for Affected Families 

    Ahmedabad Plane Tragedy: HDFC Life Simplifies Claim Submission for Affected Families 

  • PM Visits Crash Site, Meets Officials and Teams Working Tirelessly

    PM Visits Crash Site, Meets Officials and Teams Working Tirelessly

  • India–Sweden Business Roundtable Highlights Investment Scope in Key Sectors

    India–Sweden Business Roundtable Highlights Investment Scope in Key Sectors

  • JioBlackRock Investment Advisers Receives SEBI Approval to Launch Advisory Business

    JioBlackRock Investment Advisers Receives SEBI Approval to Launch Advisory Business

  • Osaka World Expo 2025: IFFCO Champions Agri-Innovation and Sustainability

    Osaka World Expo 2025: IFFCO Champions Agri-Innovation and Sustainability

Copyright © 2025 The Samikhsya. Chief Editor- Sarat Paikray
Powered by WordPress and HitMag.